Header Logo

Connection

MOSTAFA GABER to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications MOSTAFA GABER has written about Drug Evaluation, Preclinical.
MOSTAFA GABER
Connection Strength
0.027
Drug Evaluation, Preclinical
  1. Quinic acid derivative KZ-41 exhibits radiomitigating activity in preclinical models of radiation injury. Drug Dev Res. 2014 Feb; 75(1):29-36.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.